Aedifica

Accelerated Bookbuild Offering

Kempen & Co acted as Joint Global Coordinator and Joint Bookrunner in the €285.6 million capital increase of Aedifica

Private placement by way of an accelerated bookbuild offering of 2,800,000 new shares, corresponding to 8.5% of the company’s outstanding capital prior to the capital increase, with international institutional investors at an issue price of €102 per share, generating gross proceeds of €285.6 million
The issue price represented a discount of 3.87% compared to the price of the Aedifica share after close of markets on 8 June 2021 (€107.60 per share) (reduced by the estimated value of coupon no.28, representing the pro rata dividend), and a premium of 50.11% compared to the last reported net asset value
The company intends to use the net proceeds of the offering to finance execution of its committed investment program and to strengthen its balance sheet in order to pursue the company’s growth strategy through new developments and acquisitions in the European healthcare real estate market

Aedifica is a regulated real estate company under Belgian law specialised in European healthcare real estate, particularly in senior housing
The company has developed a portfolio of over 510 sites in Belgium, Germany, the Netherlands, the United Kingdom, Finland, Sweden and Ireland, worth more than €4 billion as per 31 March 2021
Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019)
Aedifica market capitalisation was approx. €3.6 billion as of 9 June 2021

Kempen has advised on Real Estate transactions in 13 different countries in Europe since 2017
This transaction underpins our leading position in European Real Estate ECM since 2011